Three medical device stocks that make solid long-term investments.
Revvity's (PKI) first-quarter results reflect the impact of transition following divestment of AES business. While earnings outpace estimates, sales miss the same.
Fresenius Medical's (FMS) first-quarter revenues benefit from strong performances across all segments, especially the North America and Asia-Pacific regions. However, rising costs hurt margins.
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q1 sales.
DaVita's (DVA) robust revenues in both segments drive its first-quarter performance.
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.